Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 8.64% Profit: QuantWave Analysis

April 10, 2025
BRISTOL-MYERS SQUIBB COMPANY, a leading pharmaceutical company, recently saw its stock reach the price target forecasted by QuantWave, generating an impressive 8.64% profit for investors. The forecast signal, issued on February 21, 2025, indicated a short direction with the stock priced at 55.23 $. On April 10, 2025, the stock hit the predicted target price of 50.46 $.

This successful forecast showcases the accuracy and efficiency of QuantWave's analytics in predicting market movements. The achievement of the price target highlights the platform's ability to provide valuable insights for investors looking to make informed decisions in the stock market.

Several factors may have contributed to the stock's movement, including industry trends, company performance, and market sentiment. QuantWave's advanced algorithms analyze a wide range of data points to generate precise forecasts, helping users navigate the complexities of the financial markets.

QuantWave is a sophisticated automated forecasting platform that offers predictions for various stocks, presenting opportunities for potential profits. Investors can benefit from the platform's insights and leverage its predictions to enhance their investment strategies. For those interested in delving deeper into QuantWave's investment approach, exploring QuantSchool's educational resources is recommended. QuantSchool offers a professional investment framework that reveals key principles for achieving consistent income using the QuantWave forecasting system.
If you want to leave a comment, then you need Login or Register





Other data for BMY

Related data

BMYJune 23, 2025Bristol Myers Squibb NYSE:BMY Set to Revolutionize Cancer Treatment with Breakthrough Drug  ~1 min.

Bristol Myers Squibb Company, a leading pharmaceutical company, is on the verge of revolutionizing cancer treatment with its groundbreaking new drug....


BMYJune 12, 2025BMY: Bristol-Myers Squibb Co. Reports Positive Phase 3 Trial Results For Sotyktu  ~1 min.

Investors are taking notice of Bristol-Myers Squibb Company, as they have recently announced positive phase 3 trial results for their drug Sotyktu. This news has caused BMY shares to rise by 3....


BMYMay 14, 2025QuantWave Successfully Achieves Price Target Forecast for Bristol-Myers Squibb Company with 14.06% Profit  ~2 min.

QuantWave, an automated forecasting platform, recently celebrated a significant achievement in its analytics with the successful price target forecast for the stock of BRISTOL-MYERS SQUIBB COMPANY....


BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Hits QuantWave Price Target with 13.0% Profit Margin  ~2 min.

On April 11, 2025, QuantWave, an automated forecasting platform, released a short signal for BRISTOL-MYERS SQUIBB COMPANY with a price target forecast of 44.12 $, indicating a 13....


BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Stock Hits Price Target with 9.09% Profit: QuantWave Forecast Success  ~2 min.

On April 23, 2025, QuantWave's forecasting platform generated a short signal for BRISTOL-MYERS SQUIBB COMPANY stock, which was trading at $47.9 at the time....


BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 12.75% Profit - QuantWave Analysis  ~1 min.

BRISTOL-MYERS SQUIBB COMPANY recently achieved the price target forecast set by QuantWave, resulting in a profitable outcome of 12.75%....


BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 11.87% Profit  ~1 min.

On May 5, 2025, QuantWave issued a short signal for BRISTOL-MYERS SQUIBB COMPANY when the stock was trading at $49.41. The forecast proved accurate as the price target of $43....


BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 11.76% Profit  ~1 min.

On April 15, 2025, QuantWave, the automated forecasting platform, issued a short signal for BRISTOL-MYERS SQUIBB COMPANY when the stock was trading at $49.35....


BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Stock Hits Target Forecast with 13.0% Profit - QuantWave Analysis  ~1 min.

On April 11, 2025, QuantWave, the automated forecasting platform, issued a short signal for BRISTOL-MYERS SQUIBB COMPANY with a price of $50.05....


BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 10.38% Profit: QuantWave Analysis  ~1 min.

BRISTOL-MYERS SQUIBB COMPANY, a renowned pharmaceutical company, recently achieved its price target forecast set by QuantWave's automated forecasting platform....


VRTXJuly 9, 2025VERTEX PHARMACEUTICALS INCORPORATED Hits QuantWave Forecast Target with 7.59% Profit  ~2 min.

VERTEX PHARMACEUTICALS INCORPORATED (VRTX) has successfully reached the forecast price target set by QuantWave on June 30, 2025....


REGNApril 4, 2025REGENERON PHARMACEUTICALS, INC. Hits QuantWave Forecast Target with Profit of 15.56%  ~1 min.

REGENERON PHARMACEUTICALS, INC. has successfully reached the price target forecast set by QuantWave on April 4, 2025....


REGNApril 4, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 16.89% Profit  ~1 min.

QuantWave's forecast for REGENERON PHARMACEUTICALS, INC. proved accurate as the stock reached the predicted target price on April 4, 2025....


REGNMay 30, 2025REGENERON PHARMACEUTICALS, INC. Stock Hits Price Target Forecast, Bringing 27.31% Profit  ~1 min.

On March 4, 2025, QuantWave, the automated forecasting platform, issued a short signal for REGENERON PHARMACEUTICALS, INC. stock when it was trading at $674.49....


BMYJuly 3, 2024BRISTOL-MYERS SQUIBB COMPANY Stock Hits Forecast Price Target with 16.99% Profit: QuantWave Analysis  ~1 min.

On April 16, 2024, QuantWave, the automated forecasting platform, issued a short signal for BRISTOL-MYERS SQUIBB COMPANY stock when it was trading at $46.0....